Qualigen Therapeutics (QLGN) Competitors $1.70 +0.03 (+1.50%) As of 02:22 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QLGN vs. BFRG, LGVN, GELS, BIVI, FLGC, LPTX, IMCC, TLPH, PHIO, and ERNAShould you be buying Qualigen Therapeutics stock or one of its competitors? The main competitors of Qualigen Therapeutics include Bullfrog AI (BFRG), Longeveron (LGVN), Gelteq (GELS), BioVie (BIVI), Flora Growth (FLGC), Leap Therapeutics (LPTX), IM Cannabis (IMCC), Talphera (TLPH), Phio Pharmaceuticals (PHIO), and Ernexa Therapeutics (ERNA). These companies are all part of the "pharmaceutical products" industry. Qualigen Therapeutics vs. Its Competitors Bullfrog AI Longeveron Gelteq BioVie Flora Growth Leap Therapeutics IM Cannabis Talphera Phio Pharmaceuticals Ernexa Therapeutics Bullfrog AI (NASDAQ:BFRG) and Qualigen Therapeutics (NASDAQ:QLGN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation. Which has more risk & volatility, BFRG or QLGN? Bullfrog AI has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, Qualigen Therapeutics has a beta of -0.15, suggesting that its share price is 115% less volatile than the S&P 500. Is BFRG or QLGN more profitable? Qualigen Therapeutics' return on equity of 0.00% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Bullfrog AIN/A -195.35% -162.37% Qualigen Therapeutics N/A N/A -202.16% Which has better earnings and valuation, BFRG or QLGN? Qualigen Therapeutics has higher revenue and earnings than Bullfrog AI. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBullfrog AI$60K189.84-$6.99M-$0.76-1.49Qualigen Therapeutics$4.98M0.58-$6.26MN/AN/A Do insiders & institutionals have more ownership in BFRG or QLGN? 1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 3.2% of Qualigen Therapeutics shares are owned by institutional investors. 24.7% of Bullfrog AI shares are owned by company insiders. Comparatively, 1.8% of Qualigen Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer BFRG or QLGN? In the previous week, Qualigen Therapeutics had 2 more articles in the media than Bullfrog AI. MarketBeat recorded 2 mentions for Qualigen Therapeutics and 0 mentions for Bullfrog AI. Qualigen Therapeutics' average media sentiment score of 0.50 beat Bullfrog AI's score of 0.00 indicating that Qualigen Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Bullfrog AI Neutral Qualigen Therapeutics Positive SummaryQualigen Therapeutics beats Bullfrog AI on 6 of the 10 factors compared between the two stocks. Get Qualigen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for QLGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QLGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QLGN vs. The Competition Export to ExcelMetricQualigen TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.88M$2.63B$5.77B$9.91BDividend YieldN/A49.35%6.67%4.51%P/E RatioN/A23.2975.8026.59Price / Sales0.58733.92555.58120.92Price / CashN/A169.7737.1158.92Price / Book-0.415.4311.446.06Net Income-$6.26M$32.95M$3.29B$266.42M7 Day Performance-5.31%1.71%0.41%-0.17%1 Month Performance-10.79%6.72%6.69%3.69%1 Year Performance-79.33%0.13%59.20%23.46% Qualigen Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QLGNQualigen TherapeuticsN/A$1.70+1.5%N/A-81.8%$2.88M$4.98M0.0050News CoverageShort Interest ↓BFRGBullfrog AI0.7708 of 5 stars$1.24+0.8%N/A-50.2%$12.50M$60K-1.634LGVNLongeveron2.6279 of 5 stars$0.82+4.6%$7.25+789.6%-65.5%$12.36M$2.39M-0.1320Short Interest ↑GELSGelteqN/A$1.30-2.3%N/AN/A$12.27MN/A0.00N/ANews CoverageGap DownBIVIBioVie0.3648 of 5 stars$1.59-3.6%N/A-94.0%$11.98MN/A-0.0210FLGCFlora Growth2.3328 of 5 stars$20.61-0.1%$93.00+351.2%-42.7%$11.95M$59.51M-0.60280Short Interest ↑Gap DownLPTXLeap Therapeutics1.6854 of 5 stars$0.29-5.5%$3.38+1,051.9%-90.3%$11.94MN/A-0.1840IMCCIM Cannabis0.1914 of 5 stars$2.27-1.5%N/A-12.8%$11.77M$39.44M-4.15340News CoverageNegative NewsShort Interest ↑Gap DownTLPHTalphera2.7856 of 5 stars$0.56-1.8%$5.00+786.5%-46.1%$11.57M$650K-1.4119Short Interest ↓Gap DownPHIOPhio Pharmaceuticals3.1554 of 5 stars$2.02+1.3%$14.00+594.8%-20.8%$11.55MN/A-0.6210Short Interest ↓ERNAErnexa Therapeutics1.0567 of 5 stars$1.50+4.7%N/A-95.3%$11.50M$580K-0.1810Short Interest ↓ Related Companies and Tools Related Companies BFRG Competitors LGVN Competitors GELS Competitors BIVI Competitors FLGC Competitors LPTX Competitors IMCC Competitors TLPH Competitors PHIO Competitors ERNA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QLGN) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QLGN Stock Alerts